Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Small Cell Lung Carcinoma × Vaccines × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1 Prostatic Neoplasms 1 Neuroectodermal Tumors, Primitive 1 Medulloblastoma 1 High Grade Cervical Intraepithelial Neoplasia 1 Glioma 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms, Male 1 Breast Neoplasms 1

Interventions

Etoposide 15 Carboplatin 14 pembrolizumab 13 Cisplatin 9 Topotecan 7 Nivolumab 7 Irinotecan 7 atezolizumab 6 Paclitaxel 5 PM 01183 5 Ipilimumab 5 Gemcitabine 5 olaparib 4 Temozolomide 4 Radiotherapy 4 surufatinib 3 durvalumab 3 carfilzomib 3 Docetaxel 3 Bevacizumab 3 veliparib 2 trilaciclib 2 sacituzumab govitecan 2 rovalpituzumab tesirine 2 obatoclax 2 navitoclax 2 lenvatinib 2 epacadostat 2 berzosertib 2 Vorinostat 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04487756 2024-04-03

VENEZO-LUNG

Instituto Oncológico Dr Rosell

Phase 1/2 Active not recruiting

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡